Introduction
NK cells are lymphoid cells that do not rearrange their TCR genes or Ig genes, and mediate MHC-unrestricted cytoxicity towards certain transformed and virally infected cells (1) (2) (3) . NK cells are also capable of specifically rejecting bone marrow allografts in lethally irradiated mice and mediate a phenomenon called 'hybrid resistance' in which H-2-heterozygous F^ hybrid mice are capable of rejecting parental H-2 homozygous bone marrow grafts to which they should be tolerant (3) (4) (5) (6) . Since NK cells can reject bone marrow allografts and not solid tissue allografts, it has been proposed that a normal physiological function of NK cells is the homeostatic regulation of hematopoiesis (3, 4, 7) . However, earlier studies examining NK cell function involved manipulation of whole populations of NK cells and produced contradictory results (7, 8) . Recently, mAb detecting subpopulations of NK cells have been characterized suggesting that different subsets of NK cells may have different target specificities or functions (9) (10) (11) . The physiological relevance of these subpopulations is not yet known. One marker present on a subset of murine NK cells, Ly-49A, has been reported to interact with class I MHC molecules (H-2D
d ; H-2D k ) and has been extensively characterized (11) (12) (13) . Binding to target cells bearing these MHC molecules appears to exert a negative signal rendering this subset of NK cells unable to lyse such targets in vitro (11, 12) . However, specific in vivo functions of this subset have yet to be delineated. Another subpopulation of murine NK cells that was positive for the marker 5E6 was demonstrated to be responsible for the specific rejection of H-2 d bone marrow grafts in H-2 b mice (9) . Only H-2 d marrow allografts were recognized by this subset. Recent evidence suggests that 5E6 also belongs to the Ly-49 family of molecules and 5E6 has been renamed Ly-49C (14) . Another marker present on a subset of NK cells called LGL-1 was also recently demonstrated to be a member of the Ly-49 family (10, 15) . + 
cells reject H-2* marrow allografts
LGL-1 has been renamed Ly-49 G2 (15) . However, like Ly-49A, its in vivo function has remained unclear (10, 15) . In vivo depletion of this subset did not significantly affect splenic NK activity towards various tumor targets (10) . We therefore wanted to determine the in vivo function of Ly-49 G2 + NK cells. We conducted bone marrow transplantation (BMT) experiments to determine the effect of depletion of this NK subset on the ability of mice to reject bone marrow allografts from various strains of mice. The results demonstrate that Ly-49 G2 + NK cells are similar to Ly-49C + NK cells in that they are responsible for mediating the specific rejection of bone marrow allografts from particular strains in mice. Specifically, Ly-49 G2 + NK cells appear to recognize and reject H-2 b bone marrow allografts in lethally irradiated mice.
Methods

Mice
bxd ) and C.B-17 scid/scid (H-2 d , SCID) mice were obtained from the Animal Production Area, NCI-FCRDC, Frederick, MD. All mice were kept under specific pathogen-free conditions until use and were not used until 8-12 weeks of age.
NK cell isolation and flow cytometric analysis
NK cells from C57BL/6 or CB6F1 mice were enriched from spleens of 12-to 16-week-old animals, using protocols that have been previously described (10) . For staining after in vivo treatment with 4D11 or anti-Ly-49 G2, mice were injected i.p. with 200 u.g of 4D11 and 2 days later were examined for effects on depletion. Briefly, spleen cell suspensions were prepared using a complete tissue culture medium containing RPMI 1640 with 10% fetal bovine serum, 2 \iM L-glutamine, and 100 units/ml of penicillin and streptomycin. The cells were then passaged over nylon wool (Robbins Scientific, Sunnyvale, CA) columns at 37°C for 1 h. The nylon wool nonadherent cells were then depleted of T cells using mAb to Ly2.2 and CD4. The B cells were removed by immunoabsorption over anti-lg coated Petri dishes. The resulting nonadherent cells were highly enriched for NK cells (1, 8) . Flow cytometric analysis was then performed to determine the percentage of 5E6 + (Ly-49C + ) cells or Ly-49 G2 + cells using a protocol that has been described previously (10) . Briefly, cells were incubated with SW5E6 (anti-Ly-49C) or 4D11 (antiLy-49 G2) mAb for 30 min at 4°C, washed and then incubated with directly flurosceinated secondary antibody for 15 min. After two washes, the cells were fixed in 1 % paraformaldehyde and analyzed on an EPICS flow cytometer (Coulter Electronics, Hialeah, FL).
BMT studies
Mice received a single injection of 0.5 mg of SW5E6 (anti-Ly-49C) i.p.; 0.2 mg of 4D11 (anti-Ly-49 G2) i.p.; 0.5 mg of PK136 (anti-NK1.1) i.p., which were all semi-purified by salt fractionation (two times) of ascites fluid; 20 jil of anti-asialo GM1 (anti-ASGM1; Wako Chemicals, Richmond, VA) i.v.; 0.2 ml normal mouse serum (NMS) i.p.; 0.2 ml normal rat serum (NRS) i.p.; or 0.2 ml normal rabbit serum (NrtS) i.v. 2 days before lethal irradiation. DBA/2 and BALB/c mice were irradiated to 850 cGy, C57BL/6 to 1000 cGy and CB6F, mice to 1100 cGy with a 137 Cs source followed by inoculation of 5X10 5 -1X10 7 bone marrow cells (BMC) i.v. The proliferation of donor cells in the spleens of recipient mice was assessed 8 days later by colony assays in soft agar.
In vitro assay for hematopoietic growth
Murine spleens were crushed and cell suspensions were prepared. The cell pellets were suspended in Iscove's medium with 15% fetal bovine serum, 1% L-glutamine, and 100 units/ ml of penicillin and streptomycin. Spleen cells (1X10 6 ) were plated in 0.3% seaplaque agar in 35 mm dishes. Optimal concentrations of growth promoting cytokines [murine IL-3 (10 ng/ml) and recombinant murine granulocyte macrophage colony stimulating factor (10 ng/ml)] were also added. Cytokines were obtained from the Biological Response Modifiers Program Repository, Frederick, MD. Plates were incubated at 37°C for 7 days and then colonies were counted. Greater than 50 cells constitutes a colony. The data are presented as total colony-forming units-culture (CFU-c) per spleen, which was obtained by multiplying number of colonies times the cellularity. A Student's Mest was performed to determine if the mean values were significantly (P < 0.05) different. Each experiment was performed three times with four mice per group. (10, 15) . In addition, 40-50% of NK 1.1 + cells were also depleted (data not shown). This suggests that the antibody treatment resulted in removal of the Ly-49 G2 + cells, not down-regulation of the determinant. We then examined the effects of depletion of the Ly-49 G2 + subset on the ability of mice to reject bone marrow allografts from different strains of mice compared with the depletion of Ly-49 C + NK cells (using SW5E6 mAb), which have been demonstrated previously to be critical for the specific rejection of H-2 d bone marrow allografts (9). We have used the splenic CFU-c assay to assess BMC engraftment in mice. The CFU-c assay is more sensitive and specific than [ 125 l]UdR incorporation assay for quantitating hematopoietic progenitor cell content in spleens of recipient mice (16 Ly-49C + or Ly-49 G2 + NK subsets on parental bone marrow graft rejection in irradiated F, hybrid mice. First, the expression of Ly-49C and Ly-49 G2 antigens was examined on resting splenic NK cells from hybrid CB6F! mice by staining with SW5E6 (anti-Ly-49 C) or 4D11 (anti-Ly-49 G2) mAb. As shown in Fig. 2, - (3, 17) . However, it has been reported that this rejection can be enhanced by using BMC that are depleted of T cells (3, 17) . We have used C.B-17 H-2 d SCID bone marrow cells as donors since it has been previously shown that the rejection pattern of congenitally T cell-deficient C.B-17 SCID BMC is identical to BALB/c BMC that were depleted of T cells (3, 17) . The data demonstrate ( Table 4) that there was significant abrogation of the rejection of H-2 d or H-2 b bone marrow grafts in F, hybrid (H-2 bxd ) mice depending upon which NK subset was depleted. Administration of anti-Ly-49 G2 in F-i mice inhibited the ability of these mice to reject parental H-2 b marrow grafts but not parental H-2 d marrow grafts. Conversely, the depletion of Ly-49C + NK cells produced the opposite result and inhibited the rejection of H-2 d marrow grafts and had no effect on the growth of H-2 b marrow grafts. Therefore, the capacity of F, (H-2 bxd ) hybrid mice to reject either parental 
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Discussion
The data presented here demonstrate that the Ly-49 G2 + NK cell subset is responsible for mediating the specific rejection of H-2 b bone marrow allografts in lethally irradiated mice. Until now, functional studies involving NK cell subsets, with the exception of Ly-49C (5E6) (9) , have primarily involved In vitro cytotoxicity assays (10) (11) (12) (13) (14) (15) . Because it has been recently demonstrated that effector cells of perforin and Fas ligand knockout mice, which are incapable of mediating cytotoxicity functions are able to reject bone marrow allografts (18, 19) The mechanism underlying this specificity is still speculative. Although T cells can play a role after 7 days in allogeneic BMT, prior sensitization is usually required (6) . T cells have also not been shown to mediate any role in rejection of parental BMC by F^ hybrid mice (3). The 'missing self theory suggests that a NK cell is in a lytic state and will lyse any target unless it receives an inhibitory signal by interaction of receptors on the NK cell with 'self class I molecules (3, 4, 20) . A FT hybrid mouse could therefore lyse both parental H-2 homozygous BMC by recognizing absence of 'self, i.e. the MHC of the opposite parent. An alternate theory proposes that recessively expressed hematopoietic histocompatability (Hh) antigens exist and these are actively recognized by the NK cells (3) (4) (5) 9) . According to this hypothesis the different NK cell subsets would be actively engaging the incompatible BMC via the different members of the Ly-49 family of receptors. Marrow allograft recognition also may or + cells reject H-2* 3 marrow allografts may not be related to the ability of all NK cells to lyse tumor targets in an MHC-unrestricted manner. There is currently little known concerning the in vivo nature of BMC recognition by the different NK cell subsets or the physiological significance of these subsets. Indeed, the best studied molecule of the Ly-49 family, Ly-49A has been extensively characterized with respect to in vitro binding and expression (11) (12) (13) (14) ; however, as yet there has been no in vivo function reported for this subset other than it appears to be deleted or downregulated in mice bearing the MHC it recognizes (21 There may be other as yet unidentified subsets of NK cells participating in the rejection process that we are currently unable to define due to the lack of antibodies to these putative subsets.
It was initially surprising that depletion of one NK subset appeared to result in an ability to significantly augment the rejection capability of the remaining subset (Table 3) . When Ly-49C + NK cells were depleted in vivo, there was a significant increase in the numbers of H-2 b BMC that could be rejected by the treated mice. There are at least two possible explanations for this result. The augmented rejection may be due to an enrichment of the Ly-49 G2 + NK cells increasing the likelihood that the H-2 b BMC will come into contact with the appropriate NK cells. If this is the case then the reason that Ly-49 G2 + NK cell depletion had no effect on H-2 d BMC engraftment is due to the fact that the Ly-49C + NK cells have been enriched. Alternatively, the different NK cell subsets may directly affect each other's activity (possibly through the production of cytokines) and removal of one subset may enhance the rejection capability of the other NK cell. Such NK cell-NK cell interactions would be a novel form of immunoregulation. Experiments are currently underway to delineate the mechanism underlying this enhanced ability to reject marrow allografts. It will also be of considerable interest to examine the Ly-49C + /Ly-49 G2 + double-positive NK cell subset in marrow rejection in Fi heterozygous mice. Can they reject both H-2 d and H-2 b BMC or are they both subject to negative signaling?
Although our BMT data indicate a role of Ly-49 G2 + NK cells in the rejection of H-2 b allografts, the normal physiological function of this or any NK cell subset remains speculative. However, it is of interest that in vivo depletion of Ly-49 G2 + NK cells did not significantly alter splenic NK activity towards tumor targets (10) whereas significant effects were detected concerning the ability of mice to reject H-2 b marrow allografts. This suggests that marrow rejection by NK cell subsets may be a more sensitive indicator of NK cell function in vivo. Interestingly, even though this subset appears to recognize H-2 b BMC, Ly-49 G2 + NK cells are also present in H-2 b mice.
It is possible that this subset can play a role in the homeostatic regulation of hematopoiesis in mice of this haplotype. Indeed, we have data demonstrating that Ly-49C + NK cells, which are responsible for mediating the rejection of H-2 d BMC, also are present in H-2 d mice but in these mice this subset is not deleterious but rather act as NK helper cells and can promote hematopoietic growth by production of growth promoting cytokines (16) . We have also observed that Ly-49C + and Ly-49C~ NK subsets act as either 'helpers' or 'suppressors' of hematopoiesis depending upon the H-2 haplotype of the mice. Analogous to observations with Ly-49C + NK cells in H-2 d mice, it is possible that in H-2 b strain mice the role of the Ly-49 G2 + NK cells is to regulate hematopoietic growth. Further studies with Ly-49 G2 + and Ly-49 G2r NK cell subsets will help elucidate their normal physiological role in hematopoiesis and in marrow rejection.
